Caxton Associates (New York)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-5,621
Closed -$289K 578
2019
Q1
$289K Buy
+5,621
New +$289K 0.04% 255